• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

当适当的抗血小板治疗未能预防支架内血栓形成时该怎么办？两例病例报告。

What should be done when appropriate antiplatelet therapy fails to prevent stent thrombosis? Two case reports.

作者信息

Hong Sungman, Song Jaegyok, Ji Sung Mi, Lee Wonkyu

机构信息

Department of Anesthesiology and Pain Medicine Dankook University College of Medicine Cheonan Republic of Korea.

出版信息

Clin Case Rep. 2023 Jun 26;11(6):e7625. doi: 10.1002/ccr3.7625. eCollection 2023 Jun.

DOI:10.1002/ccr3.7625
PMID:37384231
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10293575/
Abstract

When performing noncardiac surgery in high-risk patients with PCI, anesthesiologists should be prepared for in-stent thrombosis, that do not respond to conventional treatments and cardiopulmonary resuscitation. VA-ECMO is an advantageous treatment method in those patients.

摘要

在接受经皮冠状动脉介入治疗（PCI）的高危患者进行非心脏手术时，麻醉医生应做好应对支架内血栓形成的准备，这些血栓对常规治疗和心肺复苏均无反应。体外膜肺氧合（VA-ECMO）是这些患者的一种有利治疗方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b61/10293575/4f2a4b4acd5e/CCR3-11-e7625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b61/10293575/f901145c708b/CCR3-11-e7625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b61/10293575/4f2a4b4acd5e/CCR3-11-e7625-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b61/10293575/f901145c708b/CCR3-11-e7625-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b61/10293575/4f2a4b4acd5e/CCR3-11-e7625-g001.jpg

相似文献

1
What should be done when appropriate antiplatelet therapy fails to prevent stent thrombosis? Two case reports.当适当的抗血小板治疗未能预防支架内血栓形成时该怎么办？两例病例报告。
Clin Case Rep. 2023 Jun 26;11(6):e7625. doi: 10.1002/ccr3.7625. eCollection 2023 Jun.
2
Comparison of clinical outcomes with cangrelor plus aspirin versus oral dual antiplatelet therapy in patients supported with venoarterial extracorporeal membrane oxygenation.比较在接受静脉-动脉体外膜肺氧合支持的患者中，使用坎格雷洛联合阿司匹林与口服双联抗血小板治疗的临床结局。
Artif Organs. 2023 Oct;47(10):1672-1677. doi: 10.1111/aor.14590. Epub 2023 Jun 1.
3
Cardiopulmonary resuscitation with assisted extracorporeal life support during cardiac arrest caused by drug-eluting stent thrombosis: a case report.药物洗脱支架血栓形成导致心搏骤停时的心肺复苏联合体外辅助循环支持：病例报告。
Korean J Anesthesiol. 2014 May;66(5):383-7. doi: 10.4097/kjae.2014.66.5.383. Epub 2014 May 26.
4
Successful percutaneous coronary intervention with extracorporeal membrane oxygenation in a patient with acute inferior wall myocardial infarction complicated by electrical storm, cardiogenic shock, and cardiac arrest: a case report.体外膜肺氧合辅助下成功行经皮冠状动脉介入治疗急性下壁心肌梗死并发电风暴、心源性休克及心脏骤停 1 例报告
J Cardiothorac Surg. 2023 Jan 24;18(1):47. doi: 10.1186/s13019-023-02113-8.
5
Prolonged use of eptifibatide as a bridge to maintain drug-eluting stent patency in a patient receiving extracorporeal membrane oxygenation.在一名接受体外膜肺氧合治疗的患者中，延长使用依替巴肽作为维持药物洗脱支架通畅的过渡治疗。
Perfusion. 2018 Nov;33(8):699-703. doi: 10.1177/0267659118780802. Epub 2018 Jun 6.
6
[Outcome determinants in cardiac arrest patients secondary to acute myocardial infarction receiving extra-corporeal membrane oxygenation combined with percutaneous coronary intervention therapy].[急性心肌梗死继发心脏骤停患者接受体外膜肺氧合联合经皮冠状动脉介入治疗的预后决定因素]
Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Oct 24;45(10):867-873. doi: 10.3760/cma.j.issn.0253-3758.2017.10.011.
7
Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation.双抗血小板治疗（DAPT）与非抗血小板治疗及静脉-动脉体外膜肺氧合患者大出血发生率的比较
PLoS One. 2016 Jul 28;11(7):e0159973. doi: 10.1371/journal.pone.0159973. eCollection 2016.
8
Prophylactic veno-arterial extracorporeal membrane oxygenation in patients undergoing high-risk percutaneous coronary intervention.高危经皮冠状动脉介入治疗患者的预防性静脉-动脉体外膜肺氧合
Neth Heart J. 2020 Mar;28(3):139-144. doi: 10.1007/s12471-019-01350-8.
9
Noncardiac surgery and bleeding after percutaneous coronary intervention.非心脏手术与经皮冠状动脉介入治疗后的出血。
Circ Cardiovasc Interv. 2009 Jun;2(3):213-21. doi: 10.1161/CIRCINTERVENTIONS.108.830158. Epub 2009 Apr 21.
10
Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery.前瞻性观察性队列研究抗血小板治疗与冠状动脉支架置入术后非心脏手术患者出血和血栓形成的关系。
Br J Anaesth. 2019 Feb;122(2):170-179. doi: 10.1016/j.bja.2018.09.029. Epub 2018 Dec 15.

本文引用的文献

1
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
Circulation. 2022 May 3;145(18):e895-e1032. doi: 10.1161/CIR.0000000000001063. Epub 2022 Apr 1.
2
Overview of Veno-Arterial Extracorporeal Membrane Oxygenation (VA-ECMO) Support for the Management of Cardiogenic Shock.静脉-动脉体外膜肺氧合（VA-ECMO）支持治疗心源性休克概述
Front Cardiovasc Med. 2021 Jul 7;8:686558. doi: 10.3389/fcvm.2021.686558. eCollection 2021.
3
European Resuscitation Council Guidelines 2021: Adult advanced life support.
欧洲复苏理事会指南 2021：成人高级生命支持。
Resuscitation. 2021 Apr;161:115-151. doi: 10.1016/j.resuscitation.2021.02.010. Epub 2021 Mar 24.
4
Mechanical Support in Early Cardiogenic Shock: What Is the Role of Intra-aortic Balloon Counterpulsation?机械循环支持在早期心原性休克中的作用：主动脉内球囊反搏的作用是什么？
Curr Heart Fail Rep. 2020 Oct;17(5):247-260. doi: 10.1007/s11897-020-00480-0.
5
Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery.前瞻性观察性队列研究抗血小板治疗与冠状动脉支架置入术后非心脏手术患者出血和血栓形成的关系。
Br J Anaesth. 2019 Feb;122(2):170-179. doi: 10.1016/j.bja.2018.09.029. Epub 2018 Dec 15.
6
Cardiac Risk of Noncardiac Surgery After Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.经皮冠状动脉介入治疗第二代药物洗脱支架后非心脏手术的心脏风险。
Anesth Analg. 2019 Apr;128(4):621-628. doi: 10.1213/ANE.0000000000003408.
7
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2.多学科方法在冠状动脉支架置入术后手术患者围手术期抗栓治疗中的应用：支架术后手术 2 。
JACC Cardiovasc Interv. 2018 Mar 12;11(5):417-434. doi: 10.1016/j.jcin.2017.10.051.
8
Perioperative management of antiplatelet therapy in patients undergoing non-cardiac surgery following coronary stent placement: a systematic review.经皮冠状动脉支架置入术后非心脏手术患者抗血小板治疗的围手术期管理：系统评价。
Syst Rev. 2018 Jan 10;7(1):4. doi: 10.1186/s13643-017-0635-z.
9
Risk of non-cardiac surgery after percutaneous coronary intervention with drug-eluting stents.经皮冠状动脉介入治疗（药物洗脱支架）后非心脏手术的风险。
Sci Rep. 2017 Nov 27;7(1):16393. doi: 10.1038/s41598-017-16672-z.
10
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2016美国心脏病学会/美国心脏协会关于冠状动脉疾病患者双联抗血小板治疗持续时间的指南聚焦更新：美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2016 Sep 6;68(10):1082-115. doi: 10.1016/j.jacc.2016.03.513. Epub 2016 Mar 29.